Resistance to Glycopeptide antibiotics in staphylococcus aureus: An emerging problem?

Chemotherapy

Volumn 42, Issue , 1996, Pages 27-29

  Noble, W C ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Antibiotics; Enterococcus; Resistance; Staphylococcus; Topical; Transferable

Indexed keywords

ANTIBIOTIC AGENT; GLYCOPEPTIDE; TEICOPLANIN; TOPICAL ANTIINFECTIVE AGENT; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIAL GENETICS; CONFERENCE PAPER; ENTEROCOCCUS; GENE TRANSFER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

EID: 0029969201     PISSN: 00093157     EISSN: 14219794     Source Type: Journal    
DOI: 10.1159/000239499     Document Type: Article

References (17)

1. Woodford N, Johnson AP: Glyco-peptide resistance in Gram-positive bacteria: From black and white to shades of grey. J Med Microbiol 1994:40:375-378.
2. Vedel G, Lcrucz M, Lemann F, Hraoui E, Ratovohery D: Prevalence of Staphylococcus aureus and coagulase-ncgative staphylococci with decreased sensitivity to glyco-peptides as assessed by determination of MICs. Eur J Clin Microbiol Infect Dis 1990:9:820-822.
3. Schwalbe RS, Ritz WJ, Vcrma PR, Barranco EA, Gilligan PH: Selection for vancomycin resistance in clinical isolates of Staphylococcus haemoly-ticu. J Infect Dis 1990; 161:45-51.
4. Daum RS, Gupta S, Sabbagh R, Mi-lewski WM: Characterization of Staphylococcus aureus isolates with decreased susceptibility to vancomycin and tcicoplanin: Isolation and purification of a constitutivcly produced protein associated with decreased susceptibility. J Infect Dis 1992:166:69-72.
5. Watanakunakorn C: In vitro selection of resistance of Staphylococcus aureus to tcicoplanin and vancomycin. J Antimicrob Chemother 1990; 25:69-72.
6. Kaatz GW, Seo SM, Dorman NJ, Lcmer SA: Emergence of teicopla-nin resistance during therapy of Staphylococcus aureus endocarditis. J Infect Dis 1990;162:103-108.
7. Shlaes DM, Shlacs JH, Vincent S, Etter L, Fey PD, Goering RV: Tei-coplanin resistant Staphylococcus aureus expresses a novel membrane protein and increases expression of penicillin binding protein 2 complex. Antimicrob Agents Chemother 1993;37:2432-2437.
8. Galanakis N, Giamarellou H, Vla-chegiannis N, Dendrinos C, Daikos GK: Poor efficacy of teicop anin in treatment of deep-seated staphylococcal infection. Eur J Clin Microbiol Infect Dis 1988;7:130-134.
9. Gilbert DN, Wood CA, Kimbrough RC, The Infectious Diseases Consortium of Oregon: Failure of treatment with teicoplanin at 6 milli-grams/kilogram/day in patients with Staphylococcus aureus intravascular infection. Antimicrob Agents Chemother 1991;35:79-87.
10. O'Hare MD, Reynolds PE: Novel membrane proteins present in tcico-planin-rcsistant, vancomycin-sensitive, coagulase-negative Staphylococcus spp. J Antimicrob Chemother 1992;30:753-768.
11. Noble WC, Cree RGA, Virani Z: Co-transfer of vancomycin and other resistance genes from Enterococ-cusfaecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol Lett 1992:93:195-198.
12. Uttley AHC, George RC, Naidoo J, Woodford N, Johnson AP, Collins CH, Morrison D, Gilfillan AJ, Fitch LE, Heptonstall J: High-level vancomycin-resistant enterococci causing hospital infections. Epidemiol Infect 1989;103:173-181.
13. Hodel-Christian SL, Murray BE: Characterization of the gentamicin-resistancc transposon Tn5281 from Enterococcus faecalis and comparison with staphylococcal transposons Tn4001 and Tn4031. Antimicrob Agents Chemother 1991;35:1147- 1152.
14. Ounissi H, Derlot E, Carlier C, Courvalin P: Gene homogeneity for aminoglycoside-modifying enzymes in gram-positive cocci. Antimicrob Agents Chemother 1990:34:2164- 2168.
15. Pattersom JE, Wangcr A, Zscheck KK, Zervos MJ, Murray BE: Molecular epidemiology of p-lactamasc-producing enterococci. Antimicrob Agents Chemother 1990:34:302-305.
16. Zscheck KK, Murray BE: Evidence for a staphylococcal-like mercury resistance gene in Enterococcus faecalis. Antimicrob Agents Chemother 1990;34:1287-1289.
17. Ross J, Abate MA: Topical vancomycin for the treatment of Staphylococcus cpider midis and methicillin-resis-tant Staphylococcus aureus conjunctivitis. DICP 1990;24:1050-1053